Unknown

Dataset Information

0

MiR-497-5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin-like growth factor 1.


ABSTRACT:

Background

MicroRNAs (miRNAs) play an important regulatory role in carcinogenesis and cancer progression. Aberrant expression of miR-497-5p has been reported in various human malignancies. However, the role of miR-497-5p in hepatocellular carcinoma (HCC) remains unclear.

Results

In this study, we found that miR-497-5p was downregulated in HCC tissues. The low level of miR-497-5p in HCC tumors was correlated with aggressive clinicopathological characteristics and predicted poor prognosis in HCC patients. The overexpression of miR-497-5p significantly inhibited HCC cell proliferation, colony formation, and metastasis in vitro and vivo. Bioinformatics analysis further identified insulin-like growth factor 1 (IGF1) as a novel target of miR-497-5p in HCC cells.

Conclusion

Our study suggested that miR-497-5p regulates HCC cell survival, partially through downregulation of IGF1. Therefore, the miR-497-5p/IGF1 axis might serve as a novel therapeutic target in patients with HCC.

SUBMITTER: Xu GS 

PROVIDER: S-EPMC6785451 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

MiR-497-5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin-like growth factor 1.

Xu Guo-Shu GS   Li Zi-Wei ZW   Huang Zhi-Ping ZP   Brunicardi F Charles FC   Jia Fu F   Song Chao C   Zou Hai-Jian HJ   Sun Rui-Fen RF  

Molecular genetics & genomic medicine 20190823 10


<h4>Background</h4>MicroRNAs (miRNAs) play an important regulatory role in carcinogenesis and cancer progression. Aberrant expression of miR-497-5p has been reported in various human malignancies. However, the role of miR-497-5p in hepatocellular carcinoma (HCC) remains unclear.<h4>Results</h4>In this study, we found that miR-497-5p was downregulated in HCC tissues. The low level of miR-497-5p in HCC tumors was correlated with aggressive clinicopathological characteristics and predicted poor pro  ...[more]

Similar Datasets

| S-EPMC5295420 | biostudies-literature
| S-EPMC4821345 | biostudies-other
| S-EPMC8779717 | biostudies-literature
| S-EPMC6668076 | biostudies-literature
| S-EPMC7746836 | biostudies-literature
| S-EPMC5342721 | biostudies-literature
| S-EPMC6549920 | biostudies-literature
| S-EPMC7236190 | biostudies-literature
| S-EPMC8526270 | biostudies-literature
| S-EPMC6781988 | biostudies-literature